Stryker Buys Ortho Oncology Specialist Stanmore
This article was originally published in Clinica
Stryker Corp. laid out about $52m to buy UK-based Stanmore Implants Worldwide, enhancing its line-up of limb-salvage products for cancer patients.
You may also be interested in...
Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.